-
Something wrong with this record ?
Agent-based modelling for SARS-CoV-2 epidemic prediction and intervention assessment: A methodological appraisal
M. Maziarz, M. Zach,
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
GA ČR 19-04236S
Grantová Agentura České Republiky - International
805498
European Research Council, European Union's Horizon 2020 - International
PubMed
32820573
DOI
10.1111/jep.13459
Knihovny.cz E-resources
- MeSH
- Betacoronavirus MeSH
- COVID-19 MeSH
- Coronavirus Infections epidemiology MeSH
- Humans MeSH
- Pandemics MeSH
- SARS-CoV-2 MeSH
- Models, Statistical * MeSH
- Systems Analysis * MeSH
- Pneumonia, Viral epidemiology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: Our purpose is to assess epidemiological agent-based models-or ABMs-of the SARS-CoV-2 pandemic methodologically. The rapid spread of the outbreak requires fast-paced decision-making regarding mitigation measures. However, the evidence for the efficacy of non-pharmaceutical interventions such as imposed social distancing and school or workplace closures is scarce: few observational studies use quasi-experimental research designs, and conducting randomized controlled trials seems infeasible. Additionally, evidence from the previous coronavirus outbreaks of SARS and MERS lacks external validity, given the significant differences in contagiousness of those pathogens relative to SARS-CoV-2. To address the pressing policy questions that have emerged as a result of COVID-19, epidemiologists have produced numerous models that range from simple compartmental models to highly advanced agent-based models. These models have been criticized for involving simplifications and lacking empirical support for their assumptions. METHODS: To address these voices and methodologically appraise epidemiological ABMs, we consider AceMod (the model of the COVID-19 epidemic in Australia) as a case study of the modelling practice. RESULTS: Our example shows that, although epidemiological ABMs involve simplifications of various sorts, the key characteristics of social interactions and the spread of SARS-CoV-2 are represented sufficiently accurately. This is the case because these modellers treat empirical results as inputs for constructing modelling assumptions and rules that the agents follow; and they use calibration to assert the adequacy to benchmark variables. CONCLUSIONS: Given this, we claim that the best epidemiological ABMs are models of actual mechanisms and deliver both mechanistic and difference-making evidence. Consequently, they may also adequately describe the effects of possible interventions. Finally, we discuss the limitations of ABMs and put forward policy recommendations.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20027777
- 003
- CZ-PrNML
- 005
- 20210114152338.0
- 007
- ta
- 008
- 210105s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/jep.13459 $2 doi
- 035 __
- $a (PubMed)32820573
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Maziarz, Mariusz $u Interdisciplinary Centre for Ethics, Jagiellonian University, Kraków, Poland. Institute of Philosophy, Jagiellonian University, Kraków, Poland.
- 245 10
- $a Agent-based modelling for SARS-CoV-2 epidemic prediction and intervention assessment: A methodological appraisal / $c M. Maziarz, M. Zach,
- 520 9_
- $a BACKGROUND: Our purpose is to assess epidemiological agent-based models-or ABMs-of the SARS-CoV-2 pandemic methodologically. The rapid spread of the outbreak requires fast-paced decision-making regarding mitigation measures. However, the evidence for the efficacy of non-pharmaceutical interventions such as imposed social distancing and school or workplace closures is scarce: few observational studies use quasi-experimental research designs, and conducting randomized controlled trials seems infeasible. Additionally, evidence from the previous coronavirus outbreaks of SARS and MERS lacks external validity, given the significant differences in contagiousness of those pathogens relative to SARS-CoV-2. To address the pressing policy questions that have emerged as a result of COVID-19, epidemiologists have produced numerous models that range from simple compartmental models to highly advanced agent-based models. These models have been criticized for involving simplifications and lacking empirical support for their assumptions. METHODS: To address these voices and methodologically appraise epidemiological ABMs, we consider AceMod (the model of the COVID-19 epidemic in Australia) as a case study of the modelling practice. RESULTS: Our example shows that, although epidemiological ABMs involve simplifications of various sorts, the key characteristics of social interactions and the spread of SARS-CoV-2 are represented sufficiently accurately. This is the case because these modellers treat empirical results as inputs for constructing modelling assumptions and rules that the agents follow; and they use calibration to assert the adequacy to benchmark variables. CONCLUSIONS: Given this, we claim that the best epidemiological ABMs are models of actual mechanisms and deliver both mechanistic and difference-making evidence. Consequently, they may also adequately describe the effects of possible interventions. Finally, we discuss the limitations of ABMs and put forward policy recommendations.
- 650 _2
- $a Betacoronavirus $7 D000073640
- 650 _2
- $a COVID-19 $7 D000086382
- 650 _2
- $a koronavirové infekce $x epidemiologie $7 D018352
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a statistické modely $7 D015233
- 650 _2
- $a pandemie $7 D058873
- 650 _2
- $a virová pneumonie $x epidemiologie $7 D011024
- 650 _2
- $a SARS-CoV-2 $7 D000086402
- 650 12
- $a systémová analýza $7 D013597
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zach, Martin $u Department of Philosophy and Religious Studies, Faculty of Arts, Charles University in Prague, Prague, Czech Republic.
- 773 0_
- $w MED00006122 $t Journal of evaluation in clinical practice $x 1365-2753 $g Roč. 26, č. 5 (2020), s. 1352-1360
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32820573 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114152336 $b ABA008
- 999 __
- $a ok $b bmc $g 1608112 $s 1118957
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 26 $c 5 $d 1352-1360 $e 20200821 $i 1365-2753 $m Journal of evaluation in clinical practice $n J Eval Clin Pract $x MED00006122
- GRA __
- $a GA ČR 19-04236S $p Grantová Agentura České Republiky $2 International
- GRA __
- $a 805498 $p European Research Council, European Union's Horizon 2020 $2 International
- LZP __
- $a Pubmed-20210105